Journals / Türk Girişimsel Kardiyoloji Derg. / 2010 / Cilt: 14 - Sayı: 4

Romatizmal olmayan miyokarditler, tanı ve etyopatogenezinde problemler

Non rheumatic myocarditis. The problems of etiopathogenesis and diagnostics

Pages
164–177
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Interrelations of regulating systems with each other and consequences of their dysfunction in pathogenesis of myocarditis are shown.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The present literary review contains the latest data on problems of etiology and the mechanism of development and diagnostics of non-rheumatic myocarditis.
📊
Key Findings & Data:New classification of myocarditis and the basic pathogenetic mechanisms of development of disease are described.
💡
Conclusion & Impact:Interrelations of regulating systems with each other and consequences of their dysfunction in pathogenesis of myocarditis are shown.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The present literary review contains the latest data on problems of etiology and the mechanism of development and diagnostics of non-rheumatic myocarditis. New classification of myocarditis and the basic pathogenetic mechanisms of development of disease are described. Interrelations of regulating systems with each other and consequences of their dysfunction in pathogenesis of myocarditis are shown.

Özet

Bu makale, romatizmal olmayan myokarditlerîn etyolojisindeki problemlerdeki en son verileri, tanısı ve oluşum mekanizmasıyla ilgili bilgiler içermektedir. Yeni miyokardit sınıflandırması ve hastalığın oluşumuyla ilgili temel patogenetik mekanizmalar hastalığı tanımlamıştır. Miyokardit patogenezinde, birbirleriyle ilişkili düzenleyici sistemler ve bunların disfonksiyonunun sonuçları gösterilmiştir.

🔖

Cite This Article

BATYRALİEV, T., ZH, A. A., AVŞAR, Ö. (2022). Romatizmal olmayan miyokarditler, tanı ve etyopatogenezinde problemler. Türk Girişimsel Kardiyoloji Derg., Cilt: 14 - Sayı: 4, 164–177. https://ajindex.com/articles/624434

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Paleev N.R., Mravjan S.R., Gurevich M.A. Pathogenesis, features of clinic and diagnostics of myopericarditis. Cardiology. 2004; 5: 82-87
  2. Kishimoto C., Matsumori A., Tomioka N., Masuda T. Immunological background of patients with dilated cardiomyopathy and myocarditis: clinical and experimental studies. J. Cardiogr. Suppl. 1999; 9: 19-25
  3. Stulova M.A., Ali Shah Mian Said, Novikov Y.I. Acute virus myopericarditis and their consequences. Clinical Medicine. 1999; 9: 8-13
  4. Takehana H. Therapeutic opportunities from the pharmacological manipulation in patients with inflammatory cardiomyopathy (myocarditis): on the way to consensus. Herz. 2004; 25:200-209
  5. Paleev N.R., F.N. New in diagnostics and treatment of immune myocarditis. The Bulletin of Russian Academy of Medical Science. 2003; 12: 3-6
  6. Richardson P., McKenna W., Bristow M., et al. Report of the 2002 World Healh Organization/International Society and Federa¬tion of Cardiology Task Force on definition and classification of cardiomyophaties. Circulation. 2002;93:841-42
  7. Yamakawa K., Fukuta S., Yoshinaga T. et al. Study of immunological mechanism in dilated cardiomyopathy. Jpn. Circ. J. 2001;51:665-75
  8. Bowles N.E., Towbin J.A. Molecular aspects of myocarditis. Curr. Opin. Cardiol. 2001;13:179- 84
  9. Bekbosynova M.S. Chronic myocarditises or inflammatory form of dilated cardiomyopathy: problems of diagnostics and treatment. Clinical Medicine of Kazakhstan. 2005;1:66-72
  10. The role of chronic bacterial infection in heart disease // Clinician Publishing Group and Williams & Wilkins Clinician Reviews. 1999;9:51-52
  11. HuberS.A., Cunningham M.W. Streptococcal M protein peptide with similarity to myosin induced CD4+ T cell-dependent myocarditis in MRL/++ mice and induced partial tolerance against Cox- sackie viral myocarditis. J. Immunol. 2003;156: 3528-34
  12. Chace P.K., Hahne M., Hofmann V. et al. Modu¬lation of cytokine expression by CD 4+ T cell during Coxsackie virus B3 infections of BALB/c mice initisted by cells expressing the gamma delta+ T cell receptor. J. Virol. 2005;70:3039-44
  13. Radzhesh K. Harbanda, Hauard Svonton. Diagnostics and treatment of myocarditis. The attending physician. 2001;7:14-17
  14. Chow L.H. Pathobiology of myocarditis: from mouse to man. Heart Failure. 2000;8:5-16
  15. Maisch B., Ristic A.D., Hufnagel G. et al. Pathophysiology of viral myocarditis: the role of humoral immune response. Cardiovasc. Path. 2002;11:112-22
  16. Binah O. Immune effector mec